Company Filing History:
Years Active: 2013
Title: Mian Ying Wang: Innovator in Estrogen Regulation
Introduction
Mian Ying Wang is a notable inventor based in Rockford, IL (US). He has made significant contributions to the field of health and wellness through his innovative approach to regulating estrogen production in the human body. His work focuses on developing dietary supplements that can effectively manage estrogen levels, particularly in relation to estrogen-dependent cancers.
Latest Patents
Mian Ying Wang holds a patent for a method titled "Selectively inhibiting estrogen production and providing estrogenic effects in the human body." This invention is directed towards selectively inhibiting estrogen production while providing estrogenic effects. The dietary supplement he developed includes processed products that inhibit aromatase enzymes, which convert androgens to estrogens. It also works to inhibit receptors from binding with estrogen, thereby reducing and regulating estrogen production within the body. The methods and compositions outlined in his patent are designed to treat estrogen-dependent cancers by introducing a safe, pre-determined dosage of a nutraceutical composition.
Career Highlights
Mian Ying Wang is associated with Morinda, Inc., where he applies his expertise in health sciences to develop innovative solutions. His work has the potential to impact the treatment of various health conditions, particularly those related to hormonal imbalances.
Collaborations
Mian Ying Wang collaborates with talented individuals such as Chen Su and Afa Kehaati Palu. These partnerships enhance the research and development efforts at Morinda, Inc., fostering a collaborative environment for innovation.
Conclusion
Mian Ying Wang's contributions to the field of estrogen regulation through his patented methods highlight his role as an influential inventor. His work not only addresses critical health issues but also paves the way for future advancements in dietary supplements and cancer treatment.